# Lipocine Inc.: Form 8-K, filed Sep 11, 2026

- Company: [Lipocine Inc.](/companies/lpcn.md) (CIK 1535955)
- Form: 8-K
- Filed: 2026-09-11
- Accepted by EDGAR: Sep 11, 2026, 06:10 ET
- Period: 2026-09-08
- Accession: 0001493152-26-042286
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1535955/000149315226042286/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1535955/000149315226042286/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1535955/000149315226042286/form8-k.htm

Filed Sep 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-042286. Last ingested by Listed: Nov 5, 2026, 12:44 ET. No prices; not investment advice.
